Home
/
Hims & Hers Health, Inc.
/
Financials
/
Quarterly
Hims & Hers Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Hims & Hers Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$598.98M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$544.83M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$586.01M
May 5, 2025
Q3
2025
Sep 30, 2024
$401.56M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$315.65M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$278.17M
May 5, 2025
Q3
2024
Sep 30, 2023
$226.70M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$207.91M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$190.77M
May 6, 2024
Q3
2023
Sep 30, 2022
$144.84M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$113.56M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$101.31M
May 8, 2023
Q3
2022
Sep 30, 2021
$74.17M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$60.69M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$52.31M
May 9, 2022
Q3
2021
Sep 30, 2020
$41.32M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$35.90M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$30.06M
May 17, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$15.77M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$42.51M
Aug 4, 2025
Q3
2025
Jun 30, 2025
$42.51M
Nov 3, 2025
Q3
2025
Mar 31, 2025
$49.49M
Nov 3, 2025
Q1
2025
Mar 31, 2025
$49.49M
May 5, 2025
Q2
2025
Mar 31, 2025
$49.49M
Aug 4, 2025
Q3
2025
Sep 30, 2024
$75.59M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$13.30M
Aug 4, 2025
Q3
2025
Jun 30, 2024
$13.30M
Nov 3, 2025
Q2
2025
Mar 31, 2024
$11.13M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$11.13M
May 5, 2025
Q3
2025
Mar 31, 2024
$11.13M
Nov 3, 2025
Q3
2024
Sep 30, 2023
($7.57M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($7.16M)
Aug 5, 2024
Q3
2024
Jun 30, 2023
($7.16M)
Nov 4, 2024
Q2
2024
Mar 31, 2023
($10.07M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($10.07M)
May 6, 2024
Q3
2024
Mar 31, 2023
($10.07M)
Nov 4, 2024
Q3
2023
Sep 30, 2022
($18.84M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($19.68M)
Aug 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.81M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$26.72M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$57.90M
May 5, 2025
Q3
2025
Sep 30, 2024
$22.37M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$11.03M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$9.90M
May 5, 2025
Q3
2024
Sep 30, 2023
($8.55M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($9.24M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($11.26M)
May 6, 2024
Q3
2023
Sep 30, 2022
($19.98M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($20.19M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($16.92M)
May 8, 2023
Q3
2022
Sep 30, 2021
($27.66M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($17.41M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($48.41M)
May 9, 2022
Q3
2021
Sep 30, 2020
($3.32M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($979.0K)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($6.22M)
May 17, 2021
Q3
2020
Sep 30, 2019
($449.9K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($16.6K)
Aug 13, 2020